Aminov Erez
SEC insider (Form 3/4/5 filer). CIK 0001986112. CEO and Chairman at Telomir Pharmaceuticals, Inc. (TELO) and 1 other issuer. 24 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in MIAMI, FL.
Companies Aminov Erez has filed insider reports for
- Telomir Pharmaceuticals, Inc. (TELO): Director, Officer, CEO and Chairman
- MIRA PHARMACEUTICALS, INC. (MIRA): Director, Officer, CEO and Chairman
Aminov Erez
CIK: 0001986112
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
DispositionDirectIncentive Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
DispositionDirectNon-Qualified Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
AwardDirectIncentive Stock Options (right to buy)
2M shares- - Apr 22, 2026TELO
Telomir Pharmaceuticals, Inc.
OtherDirect7.3M shares at avg. $1.37$10.0M - Mar 30, 2026MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
83.5K shares- - Dec 17, 2025MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
3.2M shares- - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
ExerciseDirect234.6K shares at avg. $1.16$272K - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
SaleDirect613.6K shares at avg. $2.11$1.3M - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
ExerciseDirect379K shares at avg. $0.84$318K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  TELO Telomir Pharmaceuticals, Inc. | Award Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Disposition Incentive Stock Options (right to buy) | 1,960,170 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Disposition Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Award Incentive Stock Options (right to buy) | 1,960,170 | - | - | Direct |
| Apr 22, 2026 | TELO Telomir Pharmaceuticals, Inc. | Other | 7,319,710 | $1.37 | $10,028,003 | Direct |
| Mar 30, 2026 |  MIRA MIRA PHARMACEUTICALS, INC. | Award Restricted Stock Units | 83,500 | - | - | Direct |
| Dec 17, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award Stock Options (right to buy) | 3,155,170 | - | - | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Exercise | 234,595 | $1.16 | $272,130 | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Sale | 613,595 | $2.11 | $1,294,685 | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Exercise | 379,000 | $0.84 | $318,360 | Direct |
1-10 of 24 transactions